- Home
- MDXG vs ICHR Comparison
MDXG vs ICHR Comparison
Compare MDXG & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- ICHR
- Stock Information
- Founded
- MDXG 2006
- ICHR 1999
- Country
- MDXG United States
- ICHR United States
- Employees
- MDXG N/A
- ICHR N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- ICHR Semiconductors
- Sector
- MDXG Health Care
- ICHR Technology
- Exchange
- MDXG Nasdaq
- ICHR Nasdaq
- Market Cap
- MDXG 1.3B
- ICHR 1.0B
- IPO Year
- MDXG N/A
- ICHR 2016
- Fundamental
- Price
- MDXG $8.57
- ICHR $28.21
- Analyst Decision
- MDXG Strong Buy
- ICHR Strong Buy
- Analyst Count
- MDXG 5
- ICHR 8
- Target Price
- MDXG $12.00
- ICHR $42.50
- AVG Volume (30 Days)
- MDXG 617.6K
- ICHR 242.3K
- Earning Date
- MDXG 02-26-2025
- ICHR 02-04-2025
- Dividend Yield
- MDXG N/A
- ICHR N/A
- EPS Growth
- MDXG N/A
- ICHR N/A
- EPS
- MDXG 0.52
- ICHR N/A
- Revenue
- MDXG $342,804,000.00
- ICHR $819,230,000.00
- Revenue This Year
- MDXG $9.56
- ICHR $6.47
- Revenue Next Year
- MDXG $9.19
- ICHR $16.72
- P/E Ratio
- MDXG $16.49
- ICHR N/A
- Revenue Growth
- MDXG 10.93
- ICHR N/A
- 52 Week Low
- MDXG $5.47
- ICHR $25.95
- 52 Week High
- MDXG $10.14
- ICHR $46.43
- Technical
- Relative Strength Index (RSI)
- MDXG 41.31
- ICHR 41.57
- Support Level
- MDXG $8.29
- ICHR $26.19
- Resistance Level
- MDXG $9.30
- ICHR $28.63
- Average True Range (ATR)
- MDXG 0.30
- ICHR 1.44
- MACD
- MDXG -0.04
- ICHR -0.21
- Stochastic Oscillator
- MDXG 27.10
- ICHR 31.04
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About ICHR Ichor Holdings
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, the United Kingdom, Singapore, Malaysia, Korea, and Mexico, of which a majority of the revenue is generated from Singapore.